Fig. 2: Overall Survival (OS).
The 6-years OS was significnatly improved for the NCPF-Enriched cohort [70.3% (95% CI: 62–79%)] compared to the NCPF-Low cohort [56.5% (95% CI: 52.2–61%)].
Fig. 2: Overall Survival (OS). | Blood Cancer Journal
The 6-years OS was significnatly improved for the NCPF-Enriched cohort [70.3% (95% CI: 62–79%)] compared to the NCPF-Low cohort [56.5% (95% CI: 52.2–61%)].
